AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 26399225
Drug: Tailored behavioural
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tailored behavioural medicine treatment (EXT)
Trial: 26399225
Drug: Exercise-based treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Exercise-based treatment (CT)
Trial: 31693129
Drug: Intravenous zoledronic
RxNorm normalized name: Zoledronic Acid
DrugBank: Zoledronic acid (DB00399)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Intravenous zoledronic acid
Trial: 15683372
Drug: Mifepristone (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Mifepristone (200 mg)
Trial: 9658616
Drug: GenHevac B
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GenHevac B vaccine (3 standard injections at one month interval)
Trial: 18238740
Drug: Recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Recombinant human growth hormone (rhGH) therapy
Trial: 27126371
Drug: Reactive soft
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Reactive soft tissue was debrided before implant placement (Group A)
Trial: 23074313
Drug: Continuous infusion
RxNorm normalized name: insulin pump cartridge,continuous infusion,BT and controller SUBCUT EACH
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous infusion of beta-lactam antibiotics
Trial: 23944203
Drug: Intermittent bolus
RxNorm normalized name: Peumus boldus leaf extract
DrugBank: Boldo leaf extract (DB15815)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intermittent bolus administration of beta-lactam antibiotics
Trial: 12969102
Drug: Intravenous fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Intravenous fentanyl (50 micro g) plus plain bupivacaine (10 mg)
Trial: 12969102
Drug: Plain bupivacaine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Plain bupivacaine (10 mg) with saline (control)
Trial: 3885424
Drug: isoxicam 200
RxNorm normalized name: Piroxicam
DrugBank: Piroxicam (DB00554)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: isoxicam 200 mg once daily
Trial: 3885424
Drug: naproxen 250
RxNorm normalized name: naproxen 250 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: naproxen 250 mg 3 times daily
Trial: 29972757
Drug: Inotersen (300
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inotersen (300 mg weekly subcutaneous injections)
Trial: 12137101
Drug: 5 short
RxNorm normalized name: short ragweed pollen extract Sublingual Tablet [Ragwitek]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 short breaks spaced hourly during cruise
Trial: 9708636
Drug: Folinic acid
RxNorm normalized name: Folinic acid
DrugBank: Leucovorin (DB00650)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Folinic acid (FA; 500 mg/mq in 2‐hour intravenous infusion) and 5‐fluorouracil (5FU; 600 mg/mq given as an intravenous bolus 1 hour after FA) without hydroxyurea (HU) (arm A)
Trial: 7619975
Drug: 35% CO2-65%
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 35% CO2-65% O2 inhalation during early-follicular phase
Trial: 7619975
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no CO2 inhalation)
Trial: 485645
Drug: Clomiphene citrate,
RxNorm normalized name: ClomiPHENE Citrate, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate, 50 mg/day for 100 days
Trial: 485645
Drug: Clomiphene citrate,
RxNorm normalized name: ClomiPHENE Citrate, 50 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene citrate, 50 mg/day
Trial: 485645
Drug: Clomiphene therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clomiphene therapy
Trial: 26796455
Drug: 180-degree laser
RxNorm normalized name: aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 180-degree laser photolysis (LP) treatment
Trial: 26796455
Drug: 360-degree laser
RxNorm normalized name: aminosalicylic acid
DrugBank: Aminosalicylic acid (DB00233)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: 360-degree laser photolysis (LP) treatment
Trial: 14574515
Drug: Intravenous cholecystokinin
RxNorm normalized name: cholecystokinin
DrugBank: Cholecystokinin (DB08862)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intravenous cholecystokinin (CCK-8) infusion at 10 ng/kg over 3 min
Trial: 8221707
Drug: Single oral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single oral dose of 30 mg of nicardipine
Trial: 25286986
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (ATII) infusion at a starting dose of 20 ng/kg/min, titrated to maintain MAP of 65 mmHg for 6 hours
Trial: 25286986
Drug: Angiotensin II
RxNorm normalized name: Angiotensin II
DrugBank: Angiotensin II (DB11842)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Angiotensin II (ATII) infusion
Trial: 21565321
Drug: rosuvastatin 10
RxNorm normalized name: rosuvastatin 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: rosuvastatin 10 mg daily
Trial: 9491878
Drug: Estrogen replacement
RxNorm normalized name: Norethindrone Acetate 1mg, Ethinyl Estradiol 5mcg Oral tablet [Estrogen Replacement/Osteoporosis]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Estrogen replacement therapy
Trial: 9027267
Drug: Zafirlukast (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zafirlukast (20 mg twice daily)
Trial: 7769301
Drug: Menfegol foaming
RxNorm normalized name: menfegol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menfegol foaming tablets used once every other day
Trial: 7769301
Drug: Menfegol foaming
RxNorm normalized name: menfegol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menfegol foaming tablets used 1 time a day
Trial: 7769301
Drug: Menfegol foaming
RxNorm normalized name: menfegol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menfegol foaming tablets used 2 times a day
Trial: 7769301
Drug: Menfegol foaming
RxNorm normalized name: menfegol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menfegol foaming tablets used 4 times a day
Trial: 7769301
Drug: Menfegol foaming
RxNorm normalized name: menfegol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Menfegol foaming tablets used 8 times a day
Trial: 7769301
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets used < 8 times daily
Trial: 7769301
Drug: Placebo tablets
RxNorm normalized name: placebo Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo tablets used 8 times daily
Trial: 2162749
Drug: (R)-propafenone 3
RxNorm normalized name: (+)-(r)-propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (R)-propafenone 3 x 10(−6) mol/L
Trial: 2162749
Drug: (S)-propafenone 3
RxNorm normalized name: (-)-(S)-Propafenone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: (S)-propafenone 3 x 10(−6) mol/L
Trial: 11450927
Drug: Community pharmacy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Community pharmacy consultation for head lice treatment
Trial: 9503220
Drug: Somatostatin administration
RxNorm normalized name: somatostatin
DrugBank: Somatostatin (DB09099)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Somatostatin administration over a 10-day period
Trial: 15892276
Drug: Conventional treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional treatment (Control group)
Trial: 3054094
Drug: Aspirin, 3.6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aspirin, 3.6 g/day
Trial: 3054094
Drug: Diclofenac, 150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac, 150 mg/day
Trial: 12914551
Drug: 5 micro
RxNorm normalized name: Filter Connector 5 micron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 5 micro g/kg of APO
Trial: 12914551
Drug: 10 micro
RxNorm normalized name: Estradiol 10 microgram vaginal tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 10 micro g/kg of APO
Trial: 10740546
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of inhalation anaesthetics
Trial: 11561938
Drug: Fluvoxamine 100
RxNorm normalized name: fluvoxamine 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluvoxamine 100 mg/day
Trial: 1281905
Drug: High-dose chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose chemotherapy with subsequent autologous bone marrow transplantation (HDC/ABMT)
Trial: 31248067
Drug: Usual Western‐style
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual Western‐style diet enriched with 60 g/day of a mixture of nuts (nut group; n = 43)
Trial: 25018121
Drug: Once-weekly dulaglutide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly dulaglutide (1.5 mg)
Trial: 20332351
Drug: Once-daily liraglutide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily liraglutide (1.8 mg)
Trial: 25018121
Drug: Once-weekly dulaglutide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-weekly dulaglutide
Trial: 25018121
Drug: Once-daily liraglutide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Once-daily liraglutide
Trial: 21915624
Drug: GMA adjusted
RxNorm normalized name: GMA-161
DrugBank: GMA-161 (DB15397)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GMA adjusted to patients' body weight (BW), 60 mL/kg
Trial: 21915624
Drug: Routine GMA
RxNorm normalized name: GMA-161
DrugBank: GMA-161 (DB15397)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Routine GMA (fixed at 30 mL/min × 60 min)
Trial: 20613676
Drug: Calcium intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium intake (less than 500, 500 to 749, 750 to 999, 1,000 to 1,199, and 1,200 or greater mg/day)
Trial: 12788862
Drug: Flutamide (125
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Flutamide (125 mg/d) and Metformin (1275 mg/d)
Trial: 8951297
Drug: IV immune
RxNorm normalized name: GLOBULIN,IMMUNE (IV)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IV immune globulin treatment
Trial: 17215848
Drug: Amlodipine 10
RxNorm normalized name: amlodipine 10 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Amlodipine 10 mg plus Valsartan 160 mg
Trial: 12132278
Drug: Basic analgesics
RxNorm normalized name: Basic Fuchsin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Basic analgesics combined with on demand medication (group 2)
Trial: 9660994
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (120 mg daily) with or without concomitant antiretroviral agents
Trial: 9660994
Drug: Adefovir dipivoxil
RxNorm normalized name: Adefovir Dipivoxil
DrugBank: Adefovir dipivoxil (DB00718)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Adefovir dipivoxil (120 mg daily)
Trial: 7648767
Drug: Immediate-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Immediate-release formulation of racemic verapamil (240 mg)
Trial: 7648767
Drug: Sustained-release formulation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sustained-release formulation of racemic verapamil (240 mg)
Trial: 31672070
Drug: BBTI (Brief
FDA approved: no
EMA approved: no
PMDA approved: no
Description: BBTI (Brief Behavioral Treatment for Insomnia)
Trial: 23123046
Drug: short-term or
RxNorm normalized name: hydrogen peroxide
DrugBank: Hydrogen peroxide (DB11091)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: short-term or long-term therapy
Trial: 21372697
Drug: Nurse-led cognitive-behavior
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nurse-led cognitive-behavior therapy (CBT) for 6 weeks
Trial: 19921983
Drug: Dutasteride 5
RxNorm normalized name: Dutasteride 500 microgram oral capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dutasteride 5 mg/day for 5 weeks
Trial: 19921983
Drug: Serenoa repens
RxNorm normalized name: Serenoa Repens Fruit
DrugBank: Saw palmetto (DB14360)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serenoa repens 160 mg/day for 5 weeks
Trial: 16309958
Drug: Ramelteon 16
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 16 mg
Trial: 21955196
Drug: Ramelteon 32
RxNorm normalized name: Ramelteon
DrugBank: Ramelteon (DB00980)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Ramelteon 32 mg
Trial: 1302472
Drug: Chemotherapy alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alternating with radiotherapy (4 cycles of intravenous cisplatin 20 mg/m²/day for 5 days and fluorouracil 200 mg/m²/day for 5 days, alternating with radiotherapy in three 2-week courses of 20 Gy per course, 2 Gy per day, 5 days per week)
Trial: 1302472
Drug: Chemotherapy alternating
RxNorm normalized name: yellow fever virus strain 17D-204 live antigen
DrugBank: Yellow fever vaccine (DB10805)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Chemotherapy alternating with radiotherapy
Trial: 29320597
Drug: SPF 70
RxNorm normalized name: Coppertone Kids Sunscreen SPF 70
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 70 sunscreen applied at 1 mg/cm2
Trial: 29320597
Drug: SPF 15
RxNorm normalized name: Carmex Original SPF 15
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 15 sunscreen applied at 2 mg/cm2
Trial: 29320597
Drug: SPF 15
RxNorm normalized name: Carmex Original SPF 15
DrugBank: Homosalate (DB11064)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: SPF 15 sunscreen applied at 1 mg/cm2
Trial: 23008825
Drug: No preoperative
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preoperative treatment before planned radical Wertheim hysterectomy
Trial: 20353496
Drug: Active treatment
RxNorm normalized name: Activated Charcoal
DrugBank: Activated charcoal (DB09278)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Active treatment (proton pump inhibitors or H(2)-receptor antagonists)
Trial: 18671147
Drug: Albuterol Sulfate
RxNorm normalized name: Albuterol Sulfate
DrugBank: Albuterol (DB01001)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol Sulfate (90 micrograms/puff)
Trial: 18671147
Drug: Albuterol/Ipratropium bromide
RxNorm normalized name: albuterol/ipratropium bromide 20/100 MCG/INHAL Metered Dose Inhalation Spray, 120 Actuations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Albuterol/Ipratropium bromide (90 micrograms/puff/18 micrograms/puff)
Trial: 12262389
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of Depo-Provera and Depo-Testosterone
Trial: 12262389
Drug: Cessation of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cessation of drug administration
Trial: 12262389
Drug: Maintenance doses
RxNorm normalized name: Dental Resources Perio Maintenance Rinse
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Maintenance doses of the drug
Trial: 10859047
Drug: Topical treatment
RxNorm normalized name: Hongo Killer Treatment Topical Product
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical treatment with fibrin-stabilising factor XIII
Trial: 15526508
Drug: Carvedilol, 12.5
RxNorm normalized name: Carvedilol, 12.5 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol, 12.5 mg/day for six days
Trial: 3293257
Drug: Oral cyclosporine‐A
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral cyclosporine‐A (CyA) 5 mg/kg/day for an additional 6 months (open trial)
Trial: 22642697
Drug: Single 750
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single 750 mg dose telaprevir with 600 mg rifampicin
Trial: 22642697
Drug: 750 mg
RxNorm normalized name: bran 750 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 750 mg every 8 h telaprevir with 600 mg efavirenz
Trial: 21807759
Drug: Daclizumab (DAC)
RxNorm normalized name: Daclizumab
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab (DAC) high dose with interferon beta (IFNβ)
Trial: 21807759
Drug: Daclizumab (DAC)
RxNorm normalized name: Daclizumab
DrugBank: Daclizumab (DB00111)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Daclizumab (DAC) low dose with interferon beta (IFNβ)
Trial: 16194003
Drug: IVR-administered Brief
RxNorm normalized name: Ivra
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IVR-administered Brief Symptom Inventory (BSI)
Trial: 16194003
Drug: Paper-and-pencil survey
RxNorm normalized name: paper birch pollen extract
DrugBank: Betula papyrifera pollen (DB10831)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Paper-and-pencil survey administration
Trial: 7802313
Drug: Buprenorphine (0.01
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Buprenorphine (0.01 mg/kg)
Trial: 7802313
Drug: Nubain (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nubain (0.3 mg/kg)
Trial: 16093747
Drug: Morphine (0.3
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Morphine (0.3 mg/kg)
Trial: 2454140
Drug: Iloprost infusion
RxNorm normalized name: Iloprost
DrugBank: Iloprost (DB01088)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Iloprost infusion (1.0 to 3.0 ng/kg/min)
Trial: 31220957
Drug: Intralipid 20%
RxNorm normalized name: Intralipid 20% Fat Emulsion for Injection
DrugBank: Soybean oil (DB09422)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intralipid 20% infusion on the day of embryo transfer and a second dose on the day of pregnancy test
Trial: 31220957
Drug: Control group
RxNorm normalized name: meningococcal group B vaccine Prefilled Syringe [Trumenba]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control group (no intralipid therapy)
Trial: 26764317
Drug: Energy and
RxNorm normalized name: Energy And Endurance Testosterone UP
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Energy and protein supplementation (300 kcal/d, 15 g protein/d)
Trial: 24225233
Drug: Weekly Cetuximab
RxNorm normalized name: Cetuximab
DrugBank: Cetuximab (DB00002)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: Weekly Cetuximab (400 mg/m2 loading dose one week prior to radiotherapy followed by weekly 250 mg/m2)
Trial: 24225233
Drug: Concurrent daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent daily Cisplatin (6 mg/m2) and radiotherapy (66 Gy in 24 fractions) without Cetuximab
Trial: 11773508
Drug: 1000 mL/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mL/d of green tea
Trial: 11773508
Drug: 1000 mL/d
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1000 mL/d of black tea
Trial: 2104075
Drug: Omeprazole 160
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 160 mg (loading dose of 80 mg)
Trial: 6487498
Drug: Omeprazole 80
RxNorm normalized name: Omeprazole
DrugBank: Omeprazole (DB00338)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Omeprazole 80 mg
Trial: 392623
Drug: 0.2 mg
RxNorm normalized name: niacin 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.2 mg prostaglandin E2
Trial: 392623
Drug: 0.4 mg
RxNorm normalized name: biotin 0.4 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.4 mg prostaglandin E2
Trial: 22209798
Drug: Trauma-focused cognitive-behavioral
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Trauma-focused cognitive-behavioral therapy (TF-CBT)
Trial: 31142219
Drug: Direct transfer
RxNorm normalized name: direct blue 2
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Direct transfer to endovascular center (endovascular treatment stroke center)
Trial: 28865351
Drug: Exogenous testosterone
RxNorm normalized name: Testosterone
DrugBank: (1,2,6,7-3H)Testosterone (DB14093)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Exogenous testosterone (topical gel)
Trial: 2053167
Drug: EPO therapy
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: EPO therapy
Trial: 1455006
Drug: NO-EPO therapy
RxNorm normalized name: epoetin alfa
DrugBank: Erythropoietin (DB00016)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: NO-EPO therapy (Control)
Trial: 3913378
Drug: Diclofenac (32.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac (32.5 mg)
Trial: 7017781
Drug: Indomethacin (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Indomethacin (25 mg)
Trial: 22723853
Drug: Benfluorex (150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Benfluorex (150 to 450 mg/day)
Trial: 22723853
Drug: Pioglitazone (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pioglitazone (30 to 45 mg/day)
Trial: 20103455
Drug: Intramuscular phloroglucinol
RxNorm normalized name: phloroglucinol
DrugBank: Phloroglucinol (DB12944)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intramuscular phloroglucinol (4 mL)
Trial: 20103455
Drug: Placebo (normal
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (normal saline, 4 mL)
Trial: 17762547
Drug: Novel ion
RxNorm normalized name: Sulfate ion
DrugBank: Sulfate ion (DB14546)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Novel ion channel blockers targeting atrial-specific ion channels or a combination of ion channels.
Trial: 17762547
Drug: New drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: New drugs inhibiting fibrosis, cellular hypertrophy, and improving cell-cell communication.
Trial: 22999793
Drug: Insulin stimulation
RxNorm normalized name: INSULIN
DrugBank: Insulin beef (DB09456)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Insulin stimulation
Trial: 8004580
Drug: Subcutaneous heparin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Subcutaneous heparin treatment
Trial: 8004580
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no heparin treatment)
Trial: 8476405
Drug: Cognitive-behavioral group
RxNorm normalized name: Streptococcus viridans group
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive-behavioral group therapy
Trial: 31393868
Drug: 3BNC117 and
RxNorm normalized name: cytarabine and daunorubicin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 3BNC117 and 10-1074 at 10 mg/kg, one infusion